Guilherme G. Moreira is a PhD Student at Protein Misfolding and Amyloids in Biomedicine (PMAB) group (http://folding.fc.ul.pt) at Faculty of Sciences of the University of Lisbon and affiliated to BioISI Biosystems & Integrative Sciences Institute. Born in 1995, has graduated in Biochemistry (2016) and completed his master's in Medical Biochemistry (2018) at the University of Lisbon. Guilherme started his PhD studies with an FCT PhD Studentship on the PMAB GomesLab (2021) with the project entitled The calcium-binding protein S100B as a novel chaperone preventing Tau aggregation in Alzheimer's disease. Guilherme is the first author of 3 published peer-reviewed international papers (2019, 2021 and 2023), co-author of 1 published book chapter (2020) and co-author of 2 published peer-reviewed international paper (2021 and 2022), as well as author of 19 posters and 5 oral communications presented in national and international events. Has been awarded 6 travel/accommodation and registration awards for international meetings. Research Identifiers Google Scholar: https://scholar.google.com/citations?user=https://scholar.google.com/citations?user=BTcYDiYAAAAJ&hl=pt-PT&user=BTcYDiYAAAAJ Scopus: https://www.scopus.com/authid/detail.uri?authorId=57212030809 ORCID: https://orcid.org/0000-0003-4791-5403 Web Of Science: https://www.webofscience.com/wos/author/record/B-6154-2018

I am a Ph.D. student working on and fascinated by my favorite organelle in the cell- the peroxisome! During my research, I have been working on uncovering new peroxisomal proteins, and currently, I am studying their functions in this organelle and their roles in the cellular metabolism :)

I am presently a Senior Research Associate at the MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee. I have been working with a fantastic team in Prof. Dario Alessi's lab with multicultural and highly motivated people. My main project focused on exploring the Rab GTPases interactors that are linked with Parkinson's disease. I took a mass spectrometry-based approach to explore further what is binding with LRRK2-mediated phosphorylated Rab proteins and how this leads to the disease.

I have Biochemistry BSc education and had my MSc degree in Medical Biochemistry. I have gained my PhD degree on Medical Biology and Genetics. I have research experience in biochemistry, cancer biology, and tumor genetics. Most recently became a member of ISUMKAM research group at Istinye University.

IFBA certified professional in BRM, interested in Biosafety, Biosecurity and Bioethics, Research, Molecular Biology, Biostatistics, Autoimmune Diseases, Biotechnology, Molecular Biology

Subham Preetam is the Founder & CEO of N BASE. He is a professional biotechnologist in the field of biorobotics, cancer, immunity, biomedical, and nanometerial research. He is dedicated to the advancement of precision medicine and successful preclinical research to enhance the quality of life for individuals. With extensive cross-disciplinary training and experience in translational research, he is currently focused on various research topics, including microrobotics, soft bio-hybrid robots, and quantum nanoparticles for drug delivery. Furthermore, he is involved in developing a bio-fluidics nanomedicine system that leverages the latest drug delivery technologies to create personalized solutions for brain cancer. 

ovarian cancer, tissue transglutaminase, anti-tumor immune response, melanoma, stem cells, flow cytometry, biomaterials